SCHEMBL1679993

SCHEMBL1679993

CC(C)c1cccc(C(C)C)c1N1C(=O)c2ccc3c4cccc5cccc(c6ccc(c2c36)C1=O)c54

nearest known ligand 0.53

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ANPEP P15144 4/20 0.53
DPP4 P27487 4/20 0.53
NR1H2 P55055 1/20 0.49
NR1H3 Q13133 1/20 0.49
ALDH1A1 P00352 3/20 0.39
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
ADRB2 P07550 1/20 0.37
ADRB1 P08588 1/20 0.37
ADRB3 P13945 1/20 0.37
KDM4E B2RXH2 1/20 0.36
HPGD P15428 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
LMNA P02545 1/20 0.36
TP53 P04637 1/20 0.36
THRB P10828 1/20 0.36
TLR9 Q9NR96 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13478139 0.93 ANPEP (0.60) ANPEPDPP4NR1H2NR1H3MEN1
SCHEMBL18071847 0.93 ANPEP (0.60) ANPEPDPP4NR1H2NR1H3MEN1
SCHEMBL29461625 0.93 ANPEP (0.60) ANPEPDPP4NR1H2NR1H3MEN1
SCHEMBL29369271 0.93 ANPEP (0.60) ANPEPDPP4NR1H2NR1H3MEN1
SCHEMBL3438530 0.93 ANPEP (0.60) ANPEPDPP4NR1H2NR1H3MEN1
SCHEMBL17151424 0.92 ANPEP (0.56) ANPEPDPP4NR1H2NR1H3ALDH1A1
SCHEMBL2704512 0.90 ANPEP (0.55) ANPEPDPP4NR1H2NR1H3ALDH1A1
SCHEMBL6511889 0.89 ANPEP (0.45) ANPEPDPP4NR1H2NR1H3ALDH1A1
SCHEMBL17151425 0.88 ANPEP (0.52) ANPEPDPP4NR1H2NR1H3ALDH1A1
SCHEMBL13521558 0.88 ANPEP (0.52) ANPEPDPP4NR1H2NR1H3MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 57 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024144651-A1 USE OF 9-PYRROLIDINE COMPOUND AS PHOTODETECTOR ATATÜRK ÜNİVERSİTESİ FİKRİ MÜLKİYET HAKLARI KOORDİNATÖRLÜĞÜ DÖNER SERMAYE İŞLETMESİ (TR) 2024-07-04 WO disclosed
US-10739334-B2 Capsule suitable for non-invasive simultaneous oxygen content and temperature sensing in a living object MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN E.V. (DE) 2020-08-11 US disclosed
EP-3049502-B1 LONG-TERM STABLE PHOTOACTIVE COMPOSITION, SUCH AS PHOSPHORESCENT COMPOSITION OR TTA-PHOTON UPCONVERSION COMPOSITION MAX PLANCK GESELLSCHAFT (DE) 2020-04-01 EP disclosed
EP-3274420-B1 CAPSULE SUITABLE FOR NON-INVASIVE SIMULTANEOUS OXYGEN CONTENT AND TEMPERATURE SENSING IN A LIVING OBJECT MAX PLANCK GESELLSCHAFT (DE) 2019-01-30 EP disclosed
US-20180106785-A1 CAPSULE SUITABLE FOR NON-INVASIVE SIMULTANEOUS OXYGEN CONTENT AND TEMPERATURE SENSING IN A LIVING OBJECT MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN E.V. (DE) 2018-04-19 US disclosed
EP-3274420-A1 CAPSULE SUITABLE FOR NON-INVASIVE SIMULTANEOUS OXYGEN CONTENT AND TEMPERATURE SENSING IN A LIVING OBJECT Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) 2018-01-31 EP disclosed
US-20170268746-A1 HIGHLY EFFICIENT MOLECULES SHOWING RESONANT ENERGY TRANSFER PHILIPS LIGHTING HOLDING B.V. (NL) 2017-09-21 US disclosed
US-20170268746-A1 HIGHLY EFFICIENT MOLECULES SHOWING RESONANT ENERGY TRANSFER PHILIPS LIGHTING HOLDING B.V. (NL) 2017-09-21 US disclosed
WO-2016150677-A1 CAPSULE SUITABLE FOR NON-INVASIVE SIMULTANEOUS OXYGEN CONTENT AND TEMPERATURE SENSING IN A LIVING OBJECT MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) 2016-09-29 WO disclosed
EP-3072942-A1 CAPSULE SUITABLE FOR NON-INVASIVE SIMULTANEOUS OXYGEN CONTENT AND TEMPERATURE SENSING IN A LIVING OBJECT Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) 2016-09-28 EP disclosed
CN-1910155-A Method for preparing terylene-3, 4:11, 12-tetracarboxydiimide by direct synthesis BASF AG (DE) 2007-02-07 CN disclosed
US-7145010-B2 Tert-alkylphenoxy-substituted polycyclic compounds BASF AKTIENGESELLSCHAFT (DE) 2006-12-05 US disclosed
CN-1247587-C Tertiary alkyl phenoxy substituted polycyclic compound BASF AG (DE) 2006-03-29 CN disclosed
US-20050251930-A1 Method for converting perylen-3,4:9,10-tetracarboxylic acid diimides into a form suitable for use as a fluorescent dye BASFAKTIENGESELLSCHAFT (DE) 2005-11-17 US disclosed
US-20050075453-A1 Method for producing aqueous polymer dispersions containing colorants BASF AKTIENGESELLSCHAF (DE) 2005-04-07 US disclosed
CN-1525975-A Tertiary alkyl phenoxy substituted polycyclic compound �����ɷ� 2004-09-01 CN disclosed
CN-1155576-C Thermochromic rylene dyes �����ɷ� 2004-06-30 CN disclosed
US-6727318-B1 EMULSION POLYMERIZATION OF ETHYLENICALLY UNSATURATED AND DYE-COMPRISING MONOMERS IN PRESENCE OF FREE-RADICAL INITIATORS BASF AKTIENGESELLSCHAFT (DE) 2004-04-27 US disclosed
US-6486319-B1 Thermochromic rylene dyes BASF AKTIENGESELLSCHAFT (DE) 2002-11-26 US disclosed
CN-1371368-A Thermochromic rylene dyes BASF AG (DE) 2002-09-25 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10739334-B2 Capsule suitable for non-invasive simultaneous oxygen content and temperature sensing in a living object SQOR, SIRT3, NQO1 ANPEP 4716/4885DPP4 3783/4885NR1H2 2921/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.